Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT01256580
What this trial is testing

Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD

Who this might be right for
Choroidal NeovascularizationMyopiaPunctate Inner Choroidopathy (PIC)+5 more
Massachusetts Eye and Ear Infirmary
Early research (Phase 1)Ended earlyNCT03396861
What this trial is testing

Treatment of Macular Edema After Cataract Surgery with Subconjunctival Aflibercept

Who this might be right for
Irvine-Gass Syndrome
Tufts Medical Center 1
Not applicableUnknownNCT01782352
What this trial is testing

Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL)

Who this might be right for
Age-related Macular Degeneration
Brigham and Women's Hospital 25,871
Not applicableNot Yet RecruitingNCT07570355
What this trial is testing

Pterygopalatine Ganglion Stimulation for the Treatment of Geographic Atrophy

Who this might be right for
Geographic Atrophy
Shanghai Institute of Acupuncture, Moxibustion and Meridian 62
Not applicableActive Not RecruitingNCT05476926
What this trial is testing

A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion+3 more
Hoffmann-La Roche 6,000
Large-scale testing (Phase 3)Study completedNCT00709449
What this trial is testing

An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects

Who this might be right for
Macular DegenerationGlaucomaRegional Blood Flow
Medical University of Vienna 60
Testing effectiveness (Phase 2)Study completedNCT03071055
What this trial is testing

Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF

Who this might be right for
Exudative Age Related Macular Degeneration
Southeast Clinical Research Associates, LLC 20
Not applicableUnknownNCT02588378
What this trial is testing

The Role of Inflammation in AMD and Related Disorders

Who this might be right for
Age-Related Macular Degeneration
Unity Health Toronto 200
Large-scale testing (Phase 3)Study completedNCT04270747
What this trial is testing

Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD]

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration (AMD)
Amgen 576
Testing effectiveness (Phase 2)Study completedNCT05536752
What this trial is testing

QA102 Phase II Study in Subjects With Dry AMD

Who this might be right for
Dry Age-related Macular Degeneration
Smilebiotek Zhuhai Limited 150
Not applicableUnknownNCT03750149
What this trial is testing

Reading Analysis in Ophthalmologic Patients

Who this might be right for
Diabetic MaculopathyAge Related Macular DegenerationGlaucoma+1 more
Prim. Prof. Dr. Oliver Findl, MBA 100
Not applicableStudy completedNCT04522999
What this trial is testing

Study of Photobiomodulation Effect on Electroretinogram Outcomes in Dry Age-Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
LumiThera, Inc. 15
Large-scale testing (Phase 3)Study completedNCT04522167
What this trial is testing

Efficacy and Safety of the Aflibercept FYB203 Biosimilar in Comparison to Eylea® in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Bioeq GmbH 434
Testing effectiveness (Phase 2)Looking for participantsNCT06672536
What this trial is testing

Multicenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMD

Who this might be right for
nAMD
Sinocelltech Ltd. 82
Large-scale testing (Phase 3)UnknownNCT00811200
What this trial is testing

Treatment Of Radiation Retinopathy Trial

Who this might be right for
Uveal Melanoma
Leiden University Medical Center 220
Testing effectiveness (Phase 2)UnknownNCT00684853
What this trial is testing

Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD

Who this might be right for
Macular Degeneration
Federal University of São Paulo 50
Large-scale testing (Phase 3)Looking for participantsNCT07695207
What this trial is testing

Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy
SANGMYUNG innovation 266
Large-scale testing (Phase 3)Study completedNCT04047472
What this trial is testing

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 397
Large-scale testing (Phase 3)Study completedNCT00964795
What this trial is testing

Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Regeneron Pharmaceuticals 323
Not applicableStudy completedNCT04662944
What this trial is testing

A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 494
Next Page